Introduction
Renewed public concern and interest followedrecent press coverage of newly released figures on smoking 1 ,2 and a major study on cancer in Scotland". It is therefore considered appropriate to report the results of an extended prospective study carried out at the London Chest Hospital from 1966 to 1984 on 500 men all under the care of one physician and in whom lung cancer was successively diagnosed between May 1966 and April 1978. During the same period 76 women were found to have lung cancer.
Age at diagnosis: The mean age at diagnosis of the 500 men was 64 years (range 40-86 years); 53% (267) were under 65 years of age. The mean age of the 76 women was 60 years (range 40-77 years); 71% (54) were under 65 years of age.
Histological diagnosis: A histological or cytological diagnosis was obtained in 85% (424) of the men and 86% (65) of the women. The cell types are shown in Table 1 . The diagnosis in the remaining patients was made on clinical, bronchoscopic and radiological evidence.
Surgical management: Surgery was performed on 36% (181) of the men (Table 2) ; 29% (145) had resections. In 43% (213) surgery was not performed because of local extension of the cancer or metastases, and 17% (87) of the men were considered unfit for surgery because of age or poor lung function. The remaining 4% (19) refused surgery.
Radiotherapy: Radiotherapy, which was mainly palliative, was carried out in 6% (31) after surgery, and in 33% (162) of other cases.
Survival: The patients were observed for a maximum of 18 years 7 months, and a minimum of 6 years 8 months. The study was completed on 31 December 1984 when 4% (19) of the men were still alive; 65% 
Methods
The patients were almost all East Londonersattending the chest clinic at the LondonChest Hospital and were referred by their general practitioners. They lived mainly in Hackney and Tower Hamlets, adjacent working class districts in East London. Most of the men were skilled, semi-skilled or unskilled (socioeconomic classes III, IV and V). Clinical, spirometric and radiographic examinations were carried out in all patients. Material for tissue diagnosis was taken at bronchoscopy and thoracotomy. Where tissue was not obtained for histological examination, the diagnosis was made cytologically from sputum, needle biopsyor by bronchial aspiration. Tissue was also obtained at postmortem. Histological classification was based on the WHO criteria'. Details of smoking history, including the age at starting and stopping cigarette smoking, were recorded. Follow up was aided by the Chest Clinic Visitors attached to the Chest Clinic.None of the patients was lost to follow up.
Results
Sex ratio: During the period in which the 500 men entered the study, 76 women were also entered, yielding a sex ratio of 6 Small cell carcinoma: Small cell carcinoma was found in 15% (63) of the men and 23% (15) of the women. The higher incidence in the women, whose numbers were small, was found not to be statistically significantly different from the men. Compared with other cell types, this carried the poorest prognosis: of the total of 78 patients, 83% (65)died within one year, 58% (45) in less than six months. By December 1978, 77 out of 78 had died, giving a median survival of 5 months, maximum (one patient) 21 months; the sole survivor died 3 months later, having survived 3 years after diagnosis. The mean age at diagnosis was 60 years (range 44-81 years). Surgery was carried out in only 14 patients and in 8 the diagnosis was not made until after surgery. Nine of these 14 patients were found to have unresectable carcinoma at thoracotomy. The median survival of this group was 7 months, which was not significantly different from that of the 5 patients who had had a resection (median survival 8 months). Radiotherapy alone was carried out in 35 patients including the sole survivor; the median survival in this group was 6 months. Eight other patients received combined but unplanned chemotherapy, plus (with the exception of one patient) radiotherapy. The median survival here was also 6 months, maximum 18 months (one patient). The remaining 21 patients were untreated; their median survival was only 2 months.
Tobacco smoking: Of the 500 men, 2 had never smoked, 4 were pipe smokers, and the remaining 494 had smoked cigarettes for a mean duration of 45 years. Most of these cigarette smokers, 82% (404),had started smoking between the ages of 14 and 21 years. Of the 2 non-smokers, one had adenocarcinoma, the other squamous cell carcinoma.
Of the 76 women, 10 were non-smokers: 3 of these had adenocarcinoma, 3 had squamous cell carcinoma, one had large cell carcinoma, in one the cell type was not specified and in the remaining 2 non-smokers neither histological nor cytological diagnoses were obtained. The 66 (87%) women who smoked had smoked cigarettes for a mean duration of 36 years, and most, 71% (47),had started smoking between the ages of 14 and 29 years.
Discussion
The mortality pattern of the group of patients was similar to that found in other large series in Great Britain 5 • 6 • A recent review of studies on combination chemotherapy for small cell carcinoma? showed that, at best, survival in patients with limited disease was prolonged to a median of 12-16 months; at worst, for patients with extensive disease, the median survival was not much better than that of our own patients". Actuarial survival was best for those patients with squamous cell carcinoma who had had resections. Of the patients who had survived at least 5 years, 84% (32) had undergone resection. Of our 500 men, 99% were cigarette smokers; most had started smoking at an early age, but neither the histological type of tumour nor survival was related to the amount or duration of smoking. The age at which the cancer was diagnosed was also not influenced by the amount smoked.
Since this study was started, with the gradual introduction of more sophisticated aids to diagnosisparticularly in the field of imaging techniques -the approach to treatment has changed and there is an increasing trend towards the use of combination chemotherapy. This study highlights the poor overall prognosis oflung cancer. Limited resection confers the best prognosis, but even then the 5-year survival is small. It may be that the biological behaviour of the tumour is the determining factor in prognosis rather than the treatment. Further study may be directed to identify the small group of patients with the better prognosis. It is therefore hoped that our results will form a useful baseline for comparison with future studies.
